Naltrexone for Pornography Addiction in a 14-Year-Old
I do not recommend naltrexone as first-line treatment for a 14-year-old with pornography addiction; instead, prioritize evidence-based psychotherapeutic interventions including motivational interviewing, cognitive-behavioral therapy, and family-based services, as these are the guideline-recommended approaches for adolescent behavioral concerns. 1
Why Psychotherapy First
The 2025 JAACAP guidelines explicitly outline evidence-based practices for adolescent substance use and behavioral issues 1. While pornography addiction is not a substance use disorder, the treatment framework applies to compulsive behaviors in adolescents:
- Motivational interviewing (MI) uses a non-confrontational, person-centered approach to help youth explore their behavior patterns
- Cognitive-behavioral therapy teaches self-regulation, coping skills, and strategies to identify and avoid triggering situations
- Family-based services address mediating risk factors like poor family communication and promote healthy family functioning
- Contingency management uses rewards to reinforce desirable behaviors
These interventions have established efficacy in adolescents and carry no medication-related risks 1.
The Naltrexone Evidence Gap
FDA Approval Status
Naltrexone is FDA-approved only for alcohol dependence and opioid use disorder in adults 2. The FDA label contains no pediatric dosing recommendations and no approval for use in adolescents for behavioral addictions 2.
Limited Adolescent Data
The only adolescent naltrexone study involved 21 legally adjudicated sexual offenders in an inpatient setting, using high doses (100-200 mg/day) 3. This population and context differ dramatically from a 14-year-old with pornography use concerns. A 2021 review noted that naltrexone evidence in children is "mainly derived from adult studies" with "considerable variability" 4.
Adult Case Reports Only
The pornography-specific literature consists of:
- A single 2008 case report in an adult 5
- A 2017 case of combined tobacco and pornography addiction in an adult 6
- Two 2026 case reports in adults with complex psychiatric comorbidities 7, 8
None of these involved adolescents.
Safety Considerations in Adolescents
Hepatotoxicity Risk
The FDA label warns that doses above 50 mg carry "a higher risk of hepatocellular injury" 2. Yet the adolescent sexual offender study used 100-200 mg/day 3—doses that would require careful hepatic monitoring in a 14-year-old.
Anhedonia Risk
The 2017 adult case report documented anhedonia as an adverse effect 6—particularly concerning in an adolescent whose reward system is still developing.
Developmental Concerns
A 2021 review emphasized that "developmental changes, plausible disease-specific alterations and genetic polymorphisms" should be considered when using naltrexone in pediatrics 4. The adolescent brain's reward circuitry is fundamentally different from adults.
When Medication Might Be Considered
If psychotherapy fails after 3-6 months and the behavior causes severe functional impairment (academic failure, social isolation, family crisis), only then consider pharmacological consultation with a child psychiatrist experienced in impulse control disorders.
Alternative Medication Options
Before naltrexone, consider:
SSRIs (e.g., fluoxetine, sertraline): Have pediatric approval for OCD and may address obsessive-compulsive features of compulsive sexual behavior. Better safety profile in adolescents.
N-acetylcysteine (NAC): Emerging evidence for behavioral addictions, available over-the-counter, minimal side effects.
If naltrexone is ultimately pursued:
- Start at 25 mg daily (per FDA guidance) 2
- Monitor liver function tests at baseline, 1 month, then quarterly
- Target dose 50 mg daily maximum (avoid higher doses used in the sexual offender study)
- Combine with ongoing psychotherapy (medication alone is insufficient) 2
Critical Pitfalls to Avoid
Skipping psychotherapy: The FDA label explicitly states naltrexone "is of proven value only when given as part of a comprehensive plan of management" 2. Medication without therapy fails.
Diagnostic oversimplification: Ensure this isn't better explained by OCD, ADHD, depression, trauma, or normal adolescent sexual curiosity before labeling it an "addiction."
Ignoring family dynamics: Adolescent behavioral issues rarely exist in isolation. Family therapy is essential 1.
Using adult dosing: The 100-200 mg doses from the sexual offender study 3 exceed FDA safety recommendations for single doses 2.